Wellgistics Health Files 8-K for Reg FD and Exhibits
Ticker: WGRX · Form: 8-K · Filed: Oct 17, 2025 · CIK: 2030763
Sentiment: neutral
Topics: disclosure, exhibits, company-name-change
TL;DR
Wellgistics Health (fka Danam Health) filed an 8-K on Oct 17 for events on Oct 13. Standard disclosure stuff.
AI Summary
Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an 8-K on October 17, 2025, reporting events as of October 13, 2025. The filing primarily concerns Regulation FD disclosures and the filing of financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Tampa, Florida.
Why It Matters
This 8-K filing indicates that Wellgistics Health is providing important updates and disclosures to the public, which could affect investor understanding of the company's current status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K for disclosures and exhibits, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- Wellgistics Health, Inc. (company) — Registrant
- Danam Health, Inc. (company) — Former company name
- October 13, 2025 (date) — Earliest event reported
- October 17, 2025 (date) — Filing date
- 3000 Bayport Drive Suite 950 Tampa, FL 33607 (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
When was Wellgistics Health, Inc. formerly known as?
Wellgistics Health, Inc. was formerly known as Danam Health, Inc., with a name change date of July 17, 2024.
What is the address of Wellgistics Health, Inc.'s principal executive offices?
The principal executive offices are located at 3000 Bayport Drive Suite 950, Tampa, FL 33607.
What is the SIC code for Wellgistics Health, Inc.?
The Standard Industrial Classification (SIC) code is 5122 for WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES.
What is the telephone number for Wellgistics Health, Inc.?
The registrant's telephone number, including area code, is (844) 203-6092.
Filing Stats: 776 words · 3 min read · ~3 pages · Grade level 12.6 · Accepted 2025-10-17 16:58:28
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share WGRX The Nasdaq
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 15KB
- ex99-1_001.jpg (GRAPHIC) — 27KB
- 0001493152-25-018500.txt ( ) — 289KB
- wgrx-20251013.xsd (EX-101.SCH) — 3KB
- wgrx-20251013_def.xml (EX-101.DEF) — 26KB
- wgrx-20251013_lab.xml (EX-101.LAB) — 33KB
- wgrx-20251013_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
01 Regulation FD
Item 7.01 Regulation FD Disclosure. On October 13, 2025, Wellgistics Health, Inc. (the "Registrant") issued a press release, a copy of which is furnished as Exhibit 99.1 hereto. The information in this Item 7.01, including Exhibits 99.1, is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to liabilities under that section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act or the Exchange Act, regardless of any general incorporation language in such filings. This Report will not be deemed an admission as to the materiality of any information of the information contained in this Item 7.01, including Exhibits 99.1. The press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. With the exception of historical matters, the matters discussed in the press releases include forward-looking statements within the meaning of applicable securities laws. Such forward-looking statements include, among others, statements regarding the Company's projects, potential financial performance, and growth opportunities. The words "believes," "expects," "intends," "plans," "anticipates," "hopes," "likely," "will," and similar expressions are intended to identify certain of these forward-looking that could cause the actual results performance or achievements of the Company (or entities in which the Company has interests), or industry results, to differ materially from future results, performance or achievements expressed or implied by such forward-looking statements. Certain factors that could cause the Company's actual future results to differ materially from those discussed are noted in connection with such statements, but other unanticipated factors could arise. Cer
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 17, 2025 WELLGISTICS HEALTH, INC. By: /s/ Prashant Patel Prashant Patel, President